| 
			
			 Roughly half of U.S. women in their 40s and 50s have dense breast 
			tissue, which increases their risk of breast cancer and makes it 
			harder to detect tumors with mammography. Several states require 
			healthcare providers to send notification letters to women whose 
			mammograms show dense breast tissue. Some states also require that 
			these higher-risk women be advised to get screened with ultrasound 
			or MRI. 
 "Dense breasts may mask small cancers on mammography," said Dr. 
			Christoph Lee, senior author of the study and a researcher at the 
			University of Washington and the Hutchinson Institute for Cancer 
			Outcomes Research in Seattle.
 
 "Ultrasound is not influenced by breast density and may detect 
			additional cancers," Lee said by email.
 
			
			 
			To see whether dense breast notification laws changed how often 
			physicians ordered screening ultrasounds for women, researchers 
			examined data from 12,787 wellness visits from 2007 to 2015 by women 
			40 to 74 years old.
 Overall, about 29% of the women had breast exams during their 
			checkups and 22% had a screening mammogram ordered, but just 3.3% 
			had screening ultrasounds ordered.
 
 Screening ultrasound rates remained persistently low throughout the 
			study period, and didn't change after states passed dense breast 
			notification laws, which were on the books in 36 states as of 
			January 2019.
 
 "Physicians may not recommend supplemental ultrasound for the 
			majority of women with dense breasts as the current evidence 
			suggests that risks outweigh benefits of screening ultrasound," Lee 
			said.
 
 With ultrasound screening, more women with tumors may detect the 
			cancer sooner, when it's easier to treat, and early detection is the 
			motivation behind many state laws recommending dense breast 
			notification. But there is also a risk of so-called over-diagnosis, 
			which can cause women to undergo needless testing or treatments for 
			relatively harmless tumors.
 
			
            [to top of second column] | 
            
			 
			It's possible some doctors and patients discuss screening 
			ultrasounds and decide the risks aren't worth it, Lee said. It's 
			also possible that physicians don't order ultrasounds because there 
			isn't a nearby radiology facility that can do these tests or because 
			insurance may not cover it.
 One limitation of the study is that researchers lacked data on how 
			many women got ultrasound screening, since the focus was on whether 
			physicians ordered the test, not whether women followed through.
 
 A previous study of dense breast notification laws found that more 
			women did get screening ultrasounds when the laws required patients 
			to be told about the benefits of additional tests like ultrasounds 
			or MRIs.
 
			In the current study, however, notification on its own didn't appear 
			to boost ultrasound screening rates.
 It's possible this study found no change in ultrasound screening 
			after dense-breast-notification laws passed because some physicians 
			recommended MRIs instead, said Dr. Richard Bleicher, leader of the 
			breast cancer program at Fox Chase Cancer Center in Philadelphia.
 
 "Breast MRIs are recommended and used frequently in women who have a 
			genetic predisposition for breast cancer; these women are those who 
			have a family history and get screened at a young age for a gene 
			mutation, or develop cancer at a young age and then get gene 
			tested," Bleicher, who wasn't involved in the study, said by email.
 
 "Since MRIs are the predominant modality used (in addition) to 
			mammography in these younger women, these are the same women who 
			typically have the densest breasts, and screening ultrasound is 
			unlikely to replace breast MRI," Bleicher said.
 
 SOURCE: https://bit.ly/2KpkX5X Journal of the American College of 
			Radiology, online July 18, 2019.
 
			[© 2019 Thomson Reuters. All rights 
				reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published, 
			broadcast, rewritten or redistributed.  
			Thompson Reuters is solely responsible for this content. |